Table 3. Clinical outcomes of the admission glucose groups.
| Admission glucose level (mg/dL) | <100 (n = 72) | 100 – 139 (n = 345) | 140 – 189 (n = 237) | 190 – 249 (n = 114) | ≥250 (n = 191) | P‐value |
|---|---|---|---|---|---|---|
| Short‐term outcomes | ||||||
| In‐hospital morbidity | 19 (26.4) | 96 (27.8) | 71 (30.0) | 39 (34.2) | 93 (48.7) | <0.001 |
| Cardiogenic shock | 13 (18.1) | 48 (13.9) | 45 (19.0) | 30 (26.3) | 70 (36.6) | <0.001 |
| Ventricular arrhythmia required defibrillation | 5 (6.9) | 43 (12.5) | 17 (7.2) | 4 (3.5) | 23 (12.0) | 0.02 |
| Sepsis | 0 (0) | 11 (3.2) | 9 (3.8) | 8 (7.0) | 19 (9.9) | 0.001 |
| Bleeding complications requiring blood transfusion | 3 (4.2) | 20 (5.8) | 11 (4.6) | 6 (5.3) | 21 (11.0) | 0.06 |
| Cardiac rupture/tamponade | 0 (0) | 2 (0.6) | 1 (0.4) | 1 (0.9) | 2 (1.0) | 0.86 |
| Acute renal failure requiring hemodialysis | 0 (0) | 3 (0.9) | 3 (0.9) | 0 (0) | 7 (3.7) | 0.03 |
| In‐hospital mortality | 6 (8.3) | 10 (2.9) | 12 (5.1) | 11 (9.6) | 41 (21.5) | <0.001 |
| In‐hospital morbidity or mortality | 22 (30.6) | 98 (28.4) | 74 (31.2) | 42 (36.8) | 93 (48.7) | <0.001 |
| Length of intensive care unit stay (day) | 2.9 ± 1.8 | 3.6 ± 4.6 | 2.6 ± 3.1 | 4.9 ± 6.0 | 4.9 ± 7.9 | 0.004 |
| Length of total hospital stay (day) | 7.6 ± 6.3 | 7.7 ± 5.9 | 8.2 ± 6.4 | 10.0 ± 8.7 | 9.6 ± 9.8 | 0.005 |
| Long‐term outcomes | ||||||
| Reinfarction | 2 (2.8) | 10 (2.9) | 4 (1.7) | 8 (7.0) | 6 (3.1) | 0.12 |
| HF required hospital admission | 6 (8.3) | 15 (4.3) | 16 (6.8) | 10 (8.8) | 20 (10.5) | 0.09 |
| Mortality at follow up | 1 (1.4) | 12 (3.5) | 14 (5.9) | 10 (8.8) | 25 (13.1) | 0.002 |
| Reinfarction or HF or mortality | 7 (9.7) | 33 (9.6) | 34 (14.3) | 20 (17.5) | 42 (22.0) | 0.001 |
| Follow up (months)† | 66.2 ± 5.9 | 64.5 ± 2.7 | 65.9 ± 3.2 | 63.0 ± 4.8 | 53.3 ± 3.6 | 0.07 |
Values are presented as numbers (%) or mean ± standard deviation (n = 959). †Values are presented as mean ± standard error. HF, heart failure.